selumetinib shrinks pediatric tumors, results of an early-phase clinical trial
Published 7 years ago • 4.2K plays • Length 2:41Download video MP4
Download video MP3
Similar videos
-
46:09
nf summit 2022: selumetinib - clinical trial success story
-
12:13
clinical trials for the treatment of nf: past, present and future; brigitte widemann, md
-
26:40
dr jim whittle, presenting: selumetinib
-
26:01
clinical trials for brain tumors
-
59:34
advancing therapies for children with rare tumors or genetic tumor predisposition syndromes
-
6:07
selumetinib in children with recurrent or refractory low-grade glioma
-
3:24
how do clinical trials help patients with cancer? | winship cancer institute
-
32:15
clinical trials for brain tumor patients | dana-farber cancer institute
-
0:41
phase 2 clinical trial | words to know, nci dictionary of cancer terms
-
1:00:25
sel-u-bration! children's tumor foundation celebrates the first fda approval for neurofibromatosis
-
0:47
phase 3 clinical trials | words to know, nci dictionary of cancer terms
-
29:04
nf forum 2016: medical treatment of plexiform neurofibromas in nf
-
49:16
beyond the standard of care: the role of clinical trials
-
49:13
clinical trials 101
-
15:34
interview with brigitte widemann, md about koselugo (selumetinib) the first fda approved drug for nf
-
1:01:10
advancing therapies for neurofibromatosis type 1 (nf1): lessons learned from every patient
-
27:18
nf forum 2015: basic update on types of drugs in clinical trials for nf1 and nf2
-
42:24
cancer cabinet community conversations: doubling clinical trials accrual
-
33:41
clinical trials for metastatic breast cancer: what you should know | dana-farber cancer institute